Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.
$16.01+0.88%
报价 2026-11-06
市值
$4.57B
EV
$7.49B
PE (TTM)
34.1x
预期 PE (FY2026)
16.3x
52 周区间距高点 -18.2%
$13.13$19.57
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 0.99 → 1.07（1.1x） | 14.9 |
| FY+32028-12 | 1.1x | 0.99 → 1.17（1.2x） | 13.6 |
毛利率 55% · TTM 收入 $1230M · 基数 EPS 0.99（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| SHCSotera Health Company | $4.57B | +0.9% | +7.3% | 55.4% | 34.1x | 13.9x | 49.5x | |
| GKOSGlaukos Corporation | $13.28B | +2.0% | +56.0% | 85.2% | – | – | 368.8x | 高增长 |
| PTGXProtagonist Therapeutics, Inc. | $8.54B | -2.4% | +959.8% | 99.2% | – | – | 147.6x | |
| OSCROscar Health, Inc. | $7.95B | -7.6% | +55.7% | 100% | 19.9x | 8.2x | 2.0x | 高增长 |
| ALKSAlkermes plc | $7.7B | +3.1% | – | 86.6% | 55.6x | 35.6x | – | |
| BLCOBausch + Lomb Corporation | $7.15B | +0.4% | +8.2% | 60.5% | – | 17.1x | 28.2x | |
| TFXTeleflex Incorporated | $6.39B | -0.8% | -30.7% | 53.3% | – | 63.6x | 26.1x | |
| MMSIMerit Medical Systems, Inc. | $5.23B | -2.7% | +7.1% | 48.7% | 31.5x | 13.5x | 20.7x | |
| OPCHOption Care Health, Inc. | $4.74B | +0.5% | +2.0% | 18.5% | 23.4x | 13.8x | 13.4x | |
| 同行中位数 | – | – | +8.2% | 72.9% | 27.4x | 15.4x | 26.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.4M | $280M | $303.4M | $311.3M | $294.3M | $254.5M | $290.2M | $285.5M |
| Gross Margin | 55.4% | 51.4% | 54.7% | 57% | 56.6% | 53.2% | 56.6% | 55.4% |
| Operating Margin | 33.2% | 30.9% | 44.9% | 35.7% | 30% | 22.4% | 30% | 28.2% |
| Net Income | $53.6M | $26.6M | $34.8M | $48.4M | $8M | $-13.3M | $12.3M | $17M |
| Diluted EPS | 0.19 | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.04 | 0.06 |
| Operating Cash Flow | $88.5M | $29.4M | $103.1M | $71.2M | $57.4M | $55.5M | $55.7M | $95.6M |